Slide 1 Heading
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here
Slide 2 Heading
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here
Slide 3 Heading
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here
Previous
Next

 

 

Wilson Sonsini Goodrich & Rosati’s legacy closely traces the birth and evolution of Silicon Valley.

 

For nearly six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.

 

Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.

Careers

We look for the best and brightest of tomorrow and develop careers from the ground up.

Add Your Heading Text Here

Add Your Heading Text Here

Add Your Heading Text Here

Leading Matters

Firm Advises Sonder on Business Combination with Gores Metropoulos II SPAC

On April 30, 2021, Sonder Holdings, a leading next-generation hospitality company that is redefining the guest experience, and Gores Metropoulos II, Inc., a special purpose acquisition company (SPAC) sponsored by an affiliate of The Gores Group, LLC and by an affiliate of Dean Metropoulos of Metropoulos & Co.,

Wilson Sonsini Advises Ceribell on $53 Million Series C Financing

On April 29, 2021, Ceribell, innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced the completion of a $53 million Series C financing, which was co-led by Longitude Capital..

Wilson Sonsini Advises Amplyx on IP Matters Related to Acquisition by Pfizer

On April 28, 2021, Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for

Digital Health Report – Q2 2021
In this issue, we discuss U.S. Food and Drug Administration (FDA) regulation of wellness devices. We also look at good commercial contracting hygiene for digital health start-ups. Other articles include recent enforcement actions against Electronic Health Records (EHR) technology vendors, and our next installment on HIPAA for digital health entrepreneurs, about proposed changes to improve individual access to PHI.